Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Mayr

Showing results (41-50 of 328) with videos related to

Pageof 33
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 8, 2012
Method for protein subfractionation of cardiovascular tissues before DIGE analysisAthanasios Didangelos, Xiaoke Yin, Manuel Mayr
Atherosclerosis|October 26, 2011
The -omics era: proteomics and lipidomics in vascular researchAthanasios Didangelos, Christin Stegemann, Manuel Mayr
Proteomics|January 10, 2017
High-density lipoproteins in high resolution: Will proteomics solve the paradox for cardiovascular risk?Ferheen Baig, Abhishek Joshi, Manuel Mayr
Molecular & Cellular Proteomics : MCP|June 25, 2023
Uncovering Protein Networks in Cardiovascular ProteomicsMaria Hasman, Manuel Mayr, Konstantinos Theofilatos
Cardiovascular Research|September 26, 2025
Precision medicine requires precision proteomics: discordance between proteomic and clinical assays in UK BiobankBhawana Singh, Ioanna Tzoulaki, Manuel Mayr
Journal of the American College of Cardiology|February 9, 2018
Cardiovascular Risk Beyond Low-Density Lipoprotein CholesterolManuel Mayr, Robert Gerszten, Stefan Kiechl
JACC. Basic to Translational Science|August 1, 2018
MicroRNA-24 and the Diabetic HeartMarieke Rienks, Abhishek Joshi, Manuel Mayr
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 25, 2018
MicroRNA-21 and the Vulnerability of Atherosclerotic PlaquesTemo Barwari, Marieke Rienks, Manuel Mayr
Trends in Cardiovascular Medicine|February 13, 2007
Proteomics and metabolomics combined in cardiovascular researchManuel Mayr, Basetti Madhu, Qingbo Xu
Circulation|September 24, 2004
Pitfalls of proteomicsManuel Mayr, Kaushik Mandal, Qingbo Xu
Pageof 33

Showing results (41-50 of 328) with videos related to

Sort By:
Pageof 33
Methods in Molecular Biology (Clifton, N.J.)|February 8, 2012
Method for protein subfractionation of cardiovascular tissues before DIGE analysisAthanasios Didangelos, Xiaoke Yin, Manuel Mayr
Atherosclerosis|October 26, 2011
The -omics era: proteomics and lipidomics in vascular researchAthanasios Didangelos, Christin Stegemann, Manuel Mayr
Proteomics|January 10, 2017
High-density lipoproteins in high resolution: Will proteomics solve the paradox for cardiovascular risk?Ferheen Baig, Abhishek Joshi, Manuel Mayr
Molecular & Cellular Proteomics : MCP|June 25, 2023
Uncovering Protein Networks in Cardiovascular ProteomicsMaria Hasman, Manuel Mayr, Konstantinos Theofilatos
Cardiovascular Research|September 26, 2025
Precision medicine requires precision proteomics: discordance between proteomic and clinical assays in UK BiobankBhawana Singh, Ioanna Tzoulaki, Manuel Mayr
Journal of the American College of Cardiology|February 9, 2018
Cardiovascular Risk Beyond Low-Density Lipoprotein CholesterolManuel Mayr, Robert Gerszten, Stefan Kiechl
JACC. Basic to Translational Science|August 1, 2018
MicroRNA-24 and the Diabetic HeartMarieke Rienks, Abhishek Joshi, Manuel Mayr
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 25, 2018
MicroRNA-21 and the Vulnerability of Atherosclerotic PlaquesTemo Barwari, Marieke Rienks, Manuel Mayr
Trends in Cardiovascular Medicine|February 13, 2007
Proteomics and metabolomics combined in cardiovascular researchManuel Mayr, Basetti Madhu, Qingbo Xu
Circulation|September 24, 2004
Pitfalls of proteomicsManuel Mayr, Kaushik Mandal, Qingbo Xu
Pageof 33